NECTA Dangerous Ideas in Drug Development - Grey Wolf
Update: 2023-09-04
Description
Today we'll be speaking with Grey Wolf Therapeutics to hear about their astounding work with ERAP inhibition to target antigen presentation in tumour cells. This novel direction is broadly applicable across many tumour types, and we'll learn about exciting exploration of the peptide library to develop specific therapies along with potential next steps for pairing with T-cell treatment.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
